Fischer Medical Ventures' subsidiary launches advanced 1.5T MRI platforms MICA and QUIN
Fischer Medical Ventures' subsidiary, Time Medical India, launched two new 1.5T MRI platforms, MICA and QUIN, at IRIA 2026. MICA is a 32-channel system with zero boil-off magnet technology. QUIN is India's first helium-free 1.5T MRI system with a 70cm bore, available in 32/64 channels. Both have received CDSCO certification.
The launch of new MRI platforms by a subsidiary is a significant business development that can enhance the company's market position and revenue potential in the medical imaging sector.
The announcement details the successful launch of new, advanced medical imaging products by the company's subsidiary, which is a positive development for the company's product portfolio and market presence.
Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, has announced the successful launch of its next-generation 1.5T MRI platforms, MICA and QUIN, at the IRIA 2026 conference. This launch represents a significant step in advancing medical imaging in India.
The IRIA 2026 conference, themed “Empowering Radiology through Technology and Innovation,” provided a platform for industry experts to explore the latest advancements. The unveiling of MICA and QUIN marked Time Medical India's entry into next-generation helium-free MRI technology, emphasizing sustainable and high-performance imaging solutions.
The MICA 1.5T 32 Channel MRI System offers high-quality imaging with enhanced patient comfort and operational efficiency, featuring cost-effective zero boil-off magnet technology and remote support services. The QUIN 1.5T Helium-Free MRI System is highlighted as India's first helium-free 1.5T wide 70 cm bore MRI system, utilizing revolutionary helium-free magnet technology, available in 32 and 64-channel configurations, and designed for improved patient comfort and lower power consumption.
Both MICA and QUIN have received CDSCO certification, ensuring compliance with Indian regulatory standards. Ms. Svetlana Rao, Director of Time Medical International Ventures (India) Pvt. Ltd., stated that these platforms redefine sustainability, performance, and patient comfort in MRI technology, empowering radiologists and clinicians with advanced imaging capabilities while ensuring cost-effective and environmentally responsible operations.
What to do with a filing like this
Fischer Medical Ventures Limited filed this with the NSE as a statutory disclosure, categorised under product launches. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fischer Medical Ventures Limited. Read the original for the full detail.